Dror Bashan
2022
In 2022, Dror Bashan earned a total compensation of $1.5M as President and Chief Executive Officer at Protalix BioTherapeutics, a 27% increase compared to previous year.
Compensation breakdown
Option Awards | $177,564 |
---|---|
Salary | $359,972 |
Stock Awards | $817,576 |
Other | $113,184 |
Total | $1,468,296 |
Bashan received $817.6K in stock awards, accounting for 56% of the total pay in 2022.
Bashan also received $177.6K in option awards, $360K in salary and $113.2K in other compensation.
Rankings
In 2022, Dror Bashan's compensation ranked 2,241st out of 5,538 executives tracked by ExecPay. In other words, Bashan earned more than 59.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,241 | 60th |
Manufacturing | 1,209 | 60th |
Chemicals And Allied Products | 532 | 61st |
Drugs | 487 | 61st |
Biological Products, Except Diagnostic Substances | 120 | 58th |
Bashan's colleagues
We found two more compensation records of executives who worked with Dror Bashan at Protalix BioTherapeutics in 2022.
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020